Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05701085 · ClinicalTrials.gov registry record · NA
Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities
A NA study of Educational Intervention and Minorities, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT05701085 is a NA study of Educational Intervention and Minorities that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 240 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05701085, a NA study of Educational Intervention and Minorities, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study focuses on psychosocial barriers at the patient level with the goal of promoting high quality decision making around clinical trials participation. The proposed study adapts the PRE-ACT model to racial and ethnic minority patients who were underrepresented in the original PRE-ACT study and will be combined with a patient navigator model.
Conditions Studied
Interventions
- OTHER Educational Intervention
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-04-24 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05701085
The ClinicalTrials.gov registry entry for NCT05701085 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Educational Intervention appearing as the primary indexed condition, and to 1 intervention - of which Educational Intervention is the first listed.
NCT05701085 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05701085 about?
NCT05701085 is a clinical study titled "Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities". This study focuses on psychosocial barriers at the patient level with the goal of promoting high quality decision making around clinical trials participation. The proposed study adapts the PRE-ACT model to racial and ethnic minority patients who were underrepresented in the original PRE-ACT study an...
What is the current status of trial NCT05701085?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-04-24. Estimated completion is 2026-12-30.
What conditions does trial NCT05701085 study?
This clinical trial studies the following conditions: Educational Intervention, Minorities.
What interventions are being tested in trial NCT05701085?
The interventions under investigation include: Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT05701085?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05701085 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.